Abstract |
Selective mutism is a multidimensional childhood disorder in which, according to the most recent studies, biologically mediated temperament and anxiety components seem to play a major role. Several psychotherapy methods have been reported in case studies to be useful, but the disorder is commonly seen to be resistant to change, particularly in cases of long duration. Currently, behaviour modification and other cognitive methods, together with cooperation with the family and the school personnel, are recommended in the treatment of selective mutism. Selective serotonin reuptake inhibitors and selective monoamine oxidase inhibitors have also been reported to be helpful when treating children with selective mutism. At the moment, pharmacotherapy cannot be recommended as the treatment of first choice but if other methods of treatment are not helpful, medication can be included in the treatment scheme. Comprehensive evaluation and treatment of possible primary and comorbid problems that require treatment are also essential.
|
Authors | Kirsti Kumpulainen |
Journal | CNS drugs
(CNS Drugs)
Vol. 16
Issue 3
Pg. 175-80
( 2002)
ISSN: 1172-7047 [Print] New Zealand |
PMID | 11888338
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anti-Anxiety Agents
- Antidepressive Agents
|
Topics |
- Anti-Anxiety Agents
(therapeutic use)
- Antidepressive Agents
(therapeutic use)
- Child
- Humans
- Mutism
(drug therapy, epidemiology, psychology, therapy)
- Psychotherapy
(methods)
|